vertex-dental dental crownsbridges
vertex-dental asia pte. ltd. - dental - a material used to manufacture partial and full crown and bridges
votrient 200 mg
novartis israel ltd - pazopanib as hydrochloride - film coated tablets - pazopanib as hydrochloride 200 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
votrient 400 mg
novartis israel ltd - pazopanib as hydrochloride - film coated tablets - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
votrient tablet 200 mg
novartis (singapore) pte ltd - pazopanib hydrochloride 216.7 mg eqv pazopanib - tablet, film coated - 200 mg - pazopanib hydrochloride 216.7 mg eqv pazopanib 200 mg
votrient tablet 400 mg
novartis (singapore) pte ltd - pazopanib hydrochloride 433.4 mg eqv pazopanib - tablet, film coated - 400 mg - pazopanib hydrochloride 433.4 mg eqv pazopanib 400 mg
votrient tablet
novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 200mg - pazopanib (pazopanib hydrochloride) 200mg - antineoplastic agents
votrient tablet
novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 400mg - pazopanib (pazopanib hydrochloride) 400mg - antineoplastic agents
votrient 400mg tablets
novartis pharmaceuticals uk ltd - pazopanib hydrochloride - tablet - 400mg
votrient 200mg tablets
novartis pharmaceuticals uk ltd - pazopanib hydrochloride - tablet - 200mg
votrient 400mg tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg